Home/Pipeline/Digital Biomarker for ILD

Digital Biomarker for ILD

Interstitial Lung Disease

Early DevelopmentActive

Key Facts

Indication

Interstitial Lung Disease

Phase

Early Development

Status

Active

Company

About electronRx

Digital‑biomarker platform that delivers continuous, AI‑powered insights for respiratory disease drug development.

View full company profile

Therapeutic Areas

COPD Asthma Interstitial Lung Disease Pulmonary Hypertension